Look at banks, NBFCs with fewer asset qualities: Ambit Capital
KV Prasad Jun 13, 2022, 06:35 AM IST (Published)
Listen to the Article (6 Minutes)
Summary
Nitin Bhasin, MD & Head-Equities Research of Ambit Capital in conversation with CNBC-TV18 said that he is overweight on IT, pharma, metals and select financials.
Nitin Bhasin, MD & Head-Equities Research of Ambit Capital in conversation with CNBC-TV18 said that he is overweight on IT, pharma, metals, and select financials.
“For last six-seven months the kind of portfolio approach we had put out was investors should be over-weight on IT stocks in India, pharma stocks in India and select exporters like chemicals and even for that matter metals,” says Bhasin.
“Alongside start looking at the banks or the NBFCs where there are less asset quality issues or valuations relatively more favourable, so that has been our portfolio approach,” he said.
Bhasin said, “One should start even looking at adding or owing names like Bharti Infratel and also relatively less expensive names like OMCs right now, hence those would dominate a portfolio.”
“The portfolio risk management in terms of what sort of an expensive names you own have to be actually start looking at in terms of growth expectation. So hence I would still maintain that metals one should remain overweight for the next 6-12 months, remain overweight on pharma and the other sectors that I mentioned.”
On metals he said, “The preference order would be Tata Steel followed by Hindalco Industries should be the ones which people should be overweight on and we maintain that.”
Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Watch this interview for more.
Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout
3 Mins Read
Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter
KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow